Status:
COMPLETED
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Systemic Capillary Leak Syndrome
Eligibility:
All Genders
1-100 years
Brief Summary
Background: * Systemic Capillary Leak Syndrome (SCLS) is a disorder of unknown cause characterized by episodes of life-threatening drop in blood pressure and leakage of fluids into tissues. The outco...
Detailed Description
The systemic capillary leak syndrome (SCLS, Clarkson syndrome) is an exceedingly rare disorder of unknown cause characterized by chronic edema or acute transient, severe episodes of hypotension, hypov...
Eligibility Criteria
Inclusion
- PARTICIPANT INCLUSION CRITERIA:
- Subjects with SCLS under 8 years of age are only eligible for components of this protocol that can occur Off Site and samples can be sent to the NIH. All SCLS subjects must be at least 8 years old to participate in any other aspects of this protocol at the NIH.
- Subjects with SCLS may enter study while pregnant and remain on study after becoming pregnant. At the discretion of the investigator, some components of this protocol will not occur while subject is pregnant.
- Diagnosis or suspected diagnosis of Systemic Capillary Leak Syndrome by a physician or documented history of capillary leak as characterized by one or more of the following:
- Hypotension (systolic blood pressure typically less than 90 mm Hg or diastolic blood pressure less than 60 mm Hg) or associated symptoms of hypotension (e.g., hypotonia \[collapse\], lightheadedness or syncope, incontinence, increased thirst)
- Laboratory evidence of hemoconcentration (e.g., hemoglobin levels above the normal range \[typically greater than17 g/dL\], elevated leukocyte counts).
- Clinical evidence of fluid extravasation (e.g. edema) and/or laboratory evidence of protein extravasation such as serum hypoalbuminemia (less than 3.5 g/dL) either chronically or during an acute hypotensive episode.
- Letter of referral, with copies of pertinent medical history and laboratory studies, from prospective study subject s referring physician. Patients may self-refer, but a letter of referral from primary physician is still required.
- Willing to donate blood for sample storage to be used for future research.
- PARTICIPANT INCLUSION CRITERIA FOR THE SUBJECT'S RELATIVES/HEALTHY VOLUNTEERS:
- Willing to donate blood for sample storage to be used for future research.
- Relatives must be at least 3 years old.
- Healthy volunteers must be at least 18 years old.
- Relatives may be pregnant or become pregnant while participating in this protocol. At the discretion of the investigator, some components of this protocol will not occur while subject is pregnant. No skin biopsies or intradermal testing will be done on pregnant relatives. Bloodwork volumes may be decreased at the discretion of the investigator.
- Healthy volunteers may not be pregnant.
- Able to give informed consent.
- PARTICIPANT EXCLUSION CRITERIA:
- Presence of conditions which, in the judgment of the investigator or the referring physician, may put the subject at undue risk for travel (including frequent episodes of severe capillary leak, symptoms not preventable by pre-medication, acute infection, severe thrombocytopenia \[minimum platelet count of 30,000/(proportionaly)L\], or significant cardiovascular disease)
- Any condition that in the view of the principal investigator would make the subject unsuitable for enrollment in this study, (i.e. medically unstable, unable to provide phlebotomy samples).
- There is an identified cause for hypotensive episodes and/or tissue swelling.
- PARTICIPANT EXCLUSION CRITERIA FOR THE SUBJECT'S RELATIVES/HEALTHY VOLUNTEERS:
- Presence of conditions which in the judgment of the investigator or the referring physician may put the subject at undue risk (i.e. medically unstable, unable to provide phlebotomy samples).
- Any condition that in the view of the principal investigator would make the subject unsuitable for enrollment in this study (i.e. medically unstable, unable to provide phlebotomy samples).
Exclusion
Key Trial Info
Start Date :
August 24 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00936325
Start Date
August 24 2009
Last Update
October 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892